@article{41a41a7c25a343809120719e32a207de,
title = "Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change",
author = "Mohyuddin, {Ghulam Rehman} and Kelly Koehn and Luciano Costa and Kumar, {Shaji K.} and Brian McClune",
note = "Funding Information: LC declares research grant funding from Amgen and Janssen; honorarium from Amgen and Sanofi; and consultant fees from Bristol-Myers Squibb, Celgene, AstraZeneca, AbbVie, and Janssen. SKK declares research funding for clinical trials from Celgene, Takeda, Janssen, Bristol-Myers Squibb, Kite, Merck, AbbVie, Medimmune, Novartis, The Mayo Clinic, Roche-Genentech, Amgen, Tenebio, and Carsgen; and consulting or advisory board participation (with no personal payments) for Celgene, Takeda, Janssen, AbbVie, Genentech, Amgen, and Molecular Partners, and (with personal payment) for Oncopeptides, Genecentrix, and Cellectar. All other authors declare no competing interests. ",
year = "2020",
month = oct,
doi = "10.1016/S2352-3026(20)30281-7",
language = "English (US)",
volume = "7",
pages = "e704--e706",
journal = "The Lancet Haematology",
issn = "2352-3026",
publisher = "Lancet Publishing Group",
number = "10",
}